Live Blogging the Vytorin Study Call

Merck and Schering-Plough postponed their earnings announcements today to wait for an update on a study of Vytorin, the cholesterol drug they co-market. (A description of the study, which looked at the drug in patients with a condition known as aortic stenosis, is online here.) Shares of both companies are down so far today. We’re [...]